Also known as: Aevi Genomic Medicine
Aevi Genomic Medicine was a genomics-focused biopharmaceutical company developing therapies for pediatric-onset life-altering diseases. It was founded in 2000, headquartered in Wayne, Pennsylvania, and later acquired by Cerecor in 2020.
Sana Biotechnology named Brian Piper executive vice president and CFO as it advanced SC451 and SG293. The company reported a fourth-quarter loss of $59 million and cash of $138 million.
Sana Biotechnology appointed Brian Piper as Executive Vice President and Chief Financial Officer on February 17, 2026. Piper brings over 25 years of biopharmaceutical financial expertise to the cell and gene therapy company.
